Saturday 17 October 2026
Export ZEPP’s income statement to Excel — free account
Zepp Health Corporation Sponsored ADR
ZEPP Technology Consumer Electronics
Zepp Health Corporation Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $258.9 million, up 41.8% from fiscal 2024. In the quarter to June 2026, revenue grew 6.93%, EPS fell 46.9%, free cash flow fell 103.7% and total debt rose 26.4%, each against the same quarter a year earlier.
3.04
0.16
−5.00%
Follow ZEPP
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | 33.72 | 29.08 | 35.00 | 17.04 | 4.20 | 3.86 | 2.06 | 2.13 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | — | — | 60.36 | 78.64 | 72.82 | 81.00 | 21.56 | 8.76 | 8.40 | 61.85 | |||||
| People | |||||||||||||||
| People | Employees | 376 | 416 | 694 | 1,132 | 1,507 | 1,227 | 987 | 839 | 765 | 763 | ||||
| Revenue/emp, $m | 0.62 | 0.76 | 0.76 | 0.74 | 0.65 | 0.80 | 0.61 | 0.42 | 0.24 | 0.34 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | 234 | 315 | 530 | 835 | 986 | 981 | 601 | 353 | 183 | 259 | ||||
| Gross margin, % | 17.74 | 24.14 | 25.77 | 25.25 | 20.71 | 20.89 | 19.39 | 26.17 | 38.46 | 38.31 | |||||
| EBT | 4 | 29 | 56 | 94 | 41 | 17 | (54) | (35) | (58) | (35) | |||||
| EBT margin, % | 1.85 | 9.37 | 10.61 | 11.22 | 4.13 | 1.71 | (8.99) | (9.81) | (31.71) | (13.70) | |||||
| Net income | 4 | 26 | 49 | 82 | 35 | 21 | (42) | (31) | (76) | (40) | |||||
| Depreciation | 0 | 1 | 1 | 2 | 4 | 8 | 8 | 8 | 5 | 5 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | 67.31 | 74.34 | 40.04 | 54.83 | 63.49 | 62.23 | 39.02 | 23.22 | 11.29 | 16.28 | ||||
| Earnings | 1.04 | 1.68 | 3.48 | 5.40 | 2.24 | 1.36 | (2.72) | (1.96) | (4.68) | (2.52) | |||||
| Cash flow | 0.75 | 8.65 | 7.77 | 4.04 | 1.55 | (2.31) | (7.42) | 2.80 | (1.51) | (1.62) | |||||
| Capex | (0.50) | (0.78) | (0.76) | (0.43) | (0.84) | (0.50) | (0.09) | 0.20 | 0.02 | (0.01) | |||||
| Free cash flow | 0.25 | 7.87 | 7.01 | 3.60 | 0.72 | (2.82) | (7.51) | 3.00 | (1.49) | (1.63) | |||||
| Book value | 1.30 | 8.28 | 19.88 | 23.56 | 26.94 | 29.21 | 25.29 | 23.21 | 15.62 | 13.49 | |||||
| Shares, m | 3 | 4 | 13 | 15 | 16 | 16 | 15 | 15 | 16 | 16 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | 0.00 | 0.13 | 11.54 | 8.97 | 21.94 | 19.80 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| P/S | 0.00 | 0.00 | 0.98 | 0.88 | 0.75 | 1.32 | 0.16 | 0.25 | 0.23 | 1.65 | |||||
| P/B | 0.00 | 0.02 | 1.98 | 2.04 | 1.76 | 2.79 | 0.25 | 0.25 | 0.17 | 2.00 | |||||
| EV/Sales | 0.00 | 0.00 | 0.54 | 0.58 | 0.48 | 1.28 | 0.32 | 0.18 | 0.26 | 1.66 | |||||
| EV/FCF | 0.00 | 0.00 | 2.14 | 2.56 | 3.10 | 8.17 | 4.52 | (15.95) | 12.75 | (36.61) | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | 3 | 37 | 103 | 61 | 24 | (36) | (114) | 43 | (24) | (26) | ||||
| Capex | (2) | (3) | (10) | (7) | (13) | (8) | (1) | 3 | 0 | 0 | |||||
| Free cash flow | 1 | 33 | 93 | 55 | 11 | (44) | (116) | 46 | (24) | (26) | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | 34 | 64 | 214 | 274 | 312 | 279 | 187 | 162 | 56 | 7 | ||||
| Total debt | 2 | 6 | 6 | 16 | 94 | 201 | 245 | 122 | 117 | 115 | |||||
| Net debt | (23) | (53) | (227) | (246) | (259) | (40) | 99 | (24) | 5 | 2 | |||||
| Shareholders’ equity | 5 | 35 | 263 | 359 | 418 | 460 | 389 | 353 | 253 | 215 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | (0.98) | 3.82 | 4.72 | 13.52 | 4.25 | 2.33 | (4.86) | (4.43) | (13.01) | (7.33) | ||||
| ROIC | 0.00 | 0.00 | 91.68 | 48.12 | 10.44 | 2.19 | (7.62) | (5.79) | (11.44) | (8.43) | |||||
| ROE | (9.29) | 35.79 | 11.07 | 26.46 | 9.02 | 4.92 | (9.84) | (8.36) | (25.02) | (17.15) | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · latest quarter Jun 2026
Charts ten years each
Zepp Health Corporation Sponsored ADR vs peers in Consumer Electronics (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| GPRO GoPro, Inc. | $215.2M | — (loss-making) | — (loss-making) | −31.26% (below 0%: shrinking) | n/m | −242.66% (below 0%: shrinking) | 30.17% | (37.15%) | Compare |
| VUZI Vuzix Corporation | $182.3M | — (loss-making) | — (loss-making) | −14.06% (below 0%: shrinking) | n/m | −23.09% (below 0%: shrinking) | (57.96%) | (696.34%) | Compare |
| UEIC Universal Electronics Inc. | $66.7M | — (loss-making) | — (loss-making) | −25.01% (below 0%: shrinking) | n/m | −22.84% (below 0%: shrinking) | 35.37% | 6.54% | Compare |
| AXIL AXIL Brands, Inc. | $37.5M | 13.7× | — | −11.17% (below 0%: shrinking) | +20.00% (above 0%: growing) | +531.52% (above 0%: growing) | 82.62% | 7.18% | Compare |
| KOSS Koss Corporation | $35.4M | — (loss-making) | 53.5× | +5.83% (above 0%: growing) | n/m | +288.26% (above 0%: growing) | 60.98% | 8.19% | Compare |
| ZEPP Zepp Health Corporation Sponsored ADR | $27.1M | — (loss-making) | 619× | +6.93% (above 0%: growing) | n/m | −103.70% (below 0%: shrinking) | 37.35% | (19.37%) | |
| FOXX Foxx Development Holdings Inc. | $17.3M | — (loss-making) | — | −49.92% (below 0%: shrinking) | n/m | +11.09% (above 0%: growing) | (26.08%) | (97.68%) | Compare |
| MSN Emerson Radio Corporation | $7.4M | — (loss-making) | 21.5× | −37.07% (below 0%: shrinking) | n/m | −66.15% (below 0%: shrinking) | 49.34% | (65.09%) | Compare |
| WLDS Wearable Devices Ltd. | $3.1M | — (loss-making) | — | −88.79% (below 0%: shrinking) | n/m | −9.83% (below 0%: shrinking) | (116.67%) | 0.00% | Compare |
| Median of peers | $36.5M | — | — | −28.13% | — | −16.33% | 32.77% | (18.57%) |
Zepp Health Corporation Sponsored ADR (ZEPP) key facts
- Strength: Zepp Health Corporation Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $258.9 million, up 41.8% from fiscal 2024.
- Zepp Health Corporation Sponsored ADR (ZEPP) is a Consumer Electronics company in the Technology sector, traded in the US as an ADR.
- As of October 16, 2026, ZEPP traded at $3.04, a market capitalization of $27.1 million.
- Return on equity was −17.2% and debt-to-equity 0.72.
- Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 1.01 (distress zone) for fiscal 2025.
Zepp Health Corporation Sponsored ADR (ZEPP) Latest News
No news at this impact. Lower the threshold for more.